About Us
Engage with the leading edge of biopharmaceuticals

Board of Directors

Chuck Scheper, Chairman

Chuck Scheper

Chuck Scheper is the chairman the board of Bexion Pharmaceuticals. Until his retirement on December 31, 2010, Chuck served as the chief operating officer at Great American Financial Resources (GAFRI), a $13 billion life and annuity services company based in Cincinnati, Ohio. Before joining GAFRI in 1997, Chuck was president and chief executive officer of Manhattan National Life Insurance Company and president of Pioneer Financial Services. He began his career in the insurance industry as vice president and controller at Union Central Life Insurance Company and before that was an audit manager at Price Waterhouse.

Chuck has been involved with numerous volunteer efforts in the community over the years. He currently is a member of the Regional Stewardship Council of Northern Kentucky’s Vision 2015, Vice Chair of the Catalytic Development Funding Corporation of Northern Kentucky, and he is a member of the World President’s Organization.

Chuck is a cancer survivor and his journey to wellness led him to become active in various causes related to cancer, including the Cancer Support Community, where he now serves as the National Board Co-Chairperson. Additionally, he works to advance cancer research through clinical trials, and also provides personal coaching and support to other cancer patients.

William P. Butler

William P. Butler

William P. Butler currently serves as Chairman of the Corporex Companies. He continues to set strategy and provide vision as he has done since 1965. Mr. Butler's efforts have grown Corporex from a one-man construction shop to a diversified real estate company with more than $1 billion of real estate assets. Additionally, Mr. Butler sponsored the formation of Eagle Hospitality Properties Trust where he was Chairman of the Board from inception in 2004 through the sale of the company in 2007.

Mr. Butler is dedicated to community service and fiduciary responsibility for shareholders. He founded The Butler Foundation and Life Learning Center, which provide community services in Northern Kentucky. Presently, he serves on the Board of Directors for the United Way of Greater Cincinnati, the Dan Beard Council of the Boy Scouts of America and the Marvin Lewis Community Fund. Additionally, Mr. Butler serves on the Board of Trustees for the Fine Arts Fund.

Mr. Butler is a graduate of The University of Cincinnati.

Dr. Lester Crawford, D.V.M., Ph.D.

Dr. Crawford

Dr. Crawford has had a distinguished career in the public and private sectors, as well as academia. He has served as FDA commissioner and as administrator of the Food Safety & Inspection Service at USDA. He has worked for the National Food Processors Association and the Association of American Veterinary Medical Colleges.

In the academic world, Dr. Crawford served in various capacities at the University of Georgia, including chair of the Department of Physiology and Pharmacology. At Georgetown University, he was director of the Center for Food and Nutrition Policy. Additionally, he has served as an expert advisor to the World Health Organization, the Singapore FDA and the U.S. National Academy of Sciences. He also served on the Committee on Scientific Freedom and Responsibility of the American Association for the Advancement of Science.

Dr. Crawford is a Member of the Institute of Medicine of the National Academy of Sciences, a Fellow of the Royal Society of Medicine in the United Kingdom, and a Fellow of the International Society of Food Science and Technology. He is the author of more than 100 scientific publications and is the co-author of four books.

Dr. Crawford has a veterinary degree from Auburn University, an honorary doctorate from Budapest University, and a PhD in pharmacology from the University of Georgia

Dr. Cameron Durrant

Dr. Cameron Durrant

Dr. Cameron Durrant is the Chairman and Chief Executive Officer of KaloBios. Dr. Durrant was the Founder of PediatRx Inc., and also the Executive Chairman of Anavex Life Sciences Corp. (AVXL:OB) a publicly traded drug development company with programs in central nervous systems disorders and cancer. He has deep experience in healthcare and pharmaceuticals and served most recently as Worldwide Vice President, Global Strategic Marketing, Infectious Diseases for Johnson & Johnson. Prior to that position he was President and CEO of Spherics, Inc. and President and CEO of PediaMed Pharmaceuticals, a private pediatrics-focused specialty pharmaceutical company. Dr. Durrant has also held executive positions with Merck & Co, Glaxo Smith Kline PLC and Pharmacia Corporation (now part of Pfizer Inc.) where he was the Global Vice President for Infectious Diseases, before taking a senior staff position.

Dr. Durrant has previously served on several public and private company boards, is an advisor to Pilgrim Software and to Saxa Private Equity Partners. Dr. Durrant holds an MBA (Masters in Business Administration) from Henley Management College at Oxford and a MB and BCh (the UK equivalent to an American MD degree) from the Welsh National School of Medicine in Cardiff, U.K. as well as several post-graduate medical qualifications, including DRCOG (Diploma of the Royal College of Obstetricians and Gynaecologists), DipCH (Diploma of Clinical and Medical Hypnotherapy) and MRCGP (Member of the Royal College of General Practitioners).

Dr. Durrant is a prior regional winner of the Ernst & Young’s "Entrepreneur of the Year". He is a regular contributor to pharmaceutical and biotech industry issues and debates and a sought after public speaker.

Timothy Schroeder

Timothy Schroeder

Timothy Schroeder, CEO and Founder of CTI Clinical Trial and Consulting Services, has over 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm has supported more than 100 drug and device approvals, and currently works on behalf of approximately 120 global pharmaceutical and biotechnology companies. Prior to founding CTI, Tim held numerous faculty positions with the University of Cincinnati College of Medicine. He was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation, which went public in 1995. Tim is currently a board member for over a dozen corporate and non-profit organizations, including Xavier University, which he attended. Tim was named as an EY Entrepreneur of the Year in 2015 and was recognized as Top Leader by the Enquirer Media in 2016.

Ray Takigiku, Ph.D.

Ray Takigiku

Previously was Director of Discovery Core Technologies, Analytical and Bioanalytical for Procter & Gamble Pharmaceuticals, and also Interim co-Director of the Genome Research Institute (now Metabolic Diseases Institute) of the College of Medicine, University of Cincinnati. Dr. Takigiku has extensive experience in leading and leveraging multifunctional teams for developing and implementing new technologies to discover, develop and provide technical support for pipeline and marketed drugs. He was part of the leadership team behind the blockbuster drug Actonel®. At P&G, Dr. Takigiku worked with global business units inside and outside of healthcare, testing and developing new models of innovation.

In addition to being a Director at Bexion, Dr. Takigiku serves on a number of Boards, including Health Source of Ohio. Dr. Takigiku received his undergraduate degrees from the University of Colorado, and Ph.D. from Indiana University.

About Us